Anticipating Reforms to the Prescription Drug User Fees Act

JAMA Netw Open. 2022 Nov 1;5(11):e2239341. doi: 10.1001/jamanetworkopen.2022.39341.

Authors

Jeromie Ballreich^{1

2}, Mariana Socal^{1

2}, Gerard F Anderson^{1

2}

Affiliations

¹ Department of Health Policy and Management, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.
² Center for Drug Safety and Effectiveness, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.

PMID: 36318213
DOI: 10.1001/jamanetworkopen.2022.39341

No abstract available

Publication types

Comment

MeSH terms

Fees and Charges
Humans
Prescription Drugs*
United States
United States Food and Drug Administration

Substances

Prescription Drugs